Dr. Eby’s research is in the genetic contribution to variability of warfarin dosing through analysis of SNPs in cytochrome 2C9, VKOR and other genes.
Charles Eby, MD, completed his formal education at Duke University (BS, Zoology) followed by medical school at Vanderbilt University (MD). Dr. Eby completed Internal Medical residency and Hematology/Oncology fellowships at the University of Rochester School of Medicine and Dentistry at Strong Memorial Hospital. He left clinical practice for a fellowship in Transfusion Medicine at Washington University School of Medicine, concentrating in laboratory hemostasis. Dr. Eby served as Medical Director for Barnes Jewish Hospital Clinical Laboratories (2011-2021), Associate (2011-2015), Co-chief (2015-2019), and Chief (2019-2021) of the Division of Laboratory and Genomic Medicine, and Interim Head of the Department of Pathology and Immunology (2018-2019).